Latest News

Oral Semaglutide Cuts MACE Risk by 14% in High-Risk Adults: Daily Dose / image credit: ©New Africa/AdobeStock
Oral Semaglutide Cuts MACE Risk by 14% in High-Risk Adults: Daily Dose

April 25th 2025

Your daily dose of the clinical news you may have missed.

Smart Ring Outperforms Apple Watch for Atrial Fibrillation Detection / image courtesy of University of Oxford
Smart Ring Outperforms Apple Watch for Atrial Fibrillation Detection

April 21st 2025

Tirzepatide Improves Heart Failure Symptoms and Renal Function in People with Obesity, CKD
Tirzepatide Improves Heart Failure Symptoms and Renal Function in People with Obesity, CKD

April 11th 2025

ACC 2025: Cardiovascular Benefits of Semaglutide 2.4 mg Highlighted in Real-World Study
ACC 2025: Cardiovascular Benefits of Semaglutide 2.4 mg Highlighted in Real-World Study

April 1st 2025

Low-Dose Colchicine 0.5 mg Reduced Total Plaque Volume in Stable CAD vs Placebo / image credit ©Tefi/stock.adobe.com
Low-Dose Colchicine 0.5 mg Reduced Total Plaque Volume in Stable CAD vs Placebo

April 1st 2025

Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.